#RefluxStop

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Implantica to Unveil Year-End Report for Q4 2025 on February 25, 2026 Implantica AG invites investors to its Year-End Report presentation for Q4 2025 on February 25, 2026, at 15:00 CET via webcast.

Implantica to Unveil Year-End Report for Q4 2025 on February 25, 2026 #MedTech #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

1 month ago

Implantica Secures Over €1.2 Million for RefluxStop® Funding in Italy Implantica AG has successfully gained more than €1.2 million in public healthcare funding for its innovative RefluxStop® device, a major achievement in Italy's healthcare landscape.

Implantica Secures Over €1.2 Million for RefluxStop® Funding in Italy #Italy #healthcare #Implantica #RefluxStop #Palermo

Thiard News@F4F

@newsen.bsky.social

3 months ago

Implantica Enhances Market Growth with RefluxStop® Launch at Careggi University Hospital in Florence, Italy Implantica AG has expanded its market presence in Italy by introducing RefluxStop® at Careggi University Hospital, a leader in innovative medical solutions.

Implantica Enhances Market Growth with RefluxStop® Launch at Careggi University Hospital in Florence, Italy #Italy #Florence #Implantica #RefluxStop #Careggi_Hospital

Thiard News@F4F

@newsen.bsky.social

3 months ago

RefluxStop® Shines at Japan Foregut Conference with Impressive 5-Year Clinical Data Insights At the recent Japan Foregut Conference, RefluxStop® was highlighted with 5-year data showcasing its effectiveness in treating GERD, impressing 120 top surgeons.

RefluxStop® Shines at Japan Foregut Conference with Impressive 5-Year Clinical Data Insights #Japan #Osaka #Implantica #GERD #RefluxStop

Thiard News@F4F

@newsen.bsky.social

4 months ago

Implantica Reports Q3 2025: FDA Approval for RefluxStop® Imminent, Strong Sales Performance Highlighted Implantica's Q3 2025 report shows strong advancement for RefluxStop® towards FDA approval with increasing sales and positive feedback.

Implantica Reports Q3 2025: FDA Approval for RefluxStop® Imminent, Strong Sales Performance Highlighted #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

4 months ago

Implantica to Present Q3 2025 Financial Results on October 31, 2025 Implantica AG is set to hold a webcast presentation for investors on October 31, 2025, detailing its third quarter financial performance.

Implantica to Present Q3 2025 Financial Results on October 31, 2025 #NASDAQ #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

5 months ago

Implantica Achieves Key Milestone in FDA Approval for RefluxStop® Device Implantica announces the successful completion of the FDA's 100-Day meeting for its RefluxStop® PMA application, marking a significant milestone.

Implantica Achieves Key Milestone in FDA Approval for RefluxStop® Device #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

5 months ago

Implantica Achieves MDSAP Recertification Signifying High Standards in Medical Device Compliance Implantica AG announces the successful completion of its MDSAP recertification audit, enhancing its commitment to safety and regulatory excellence in multiple regions.

Implantica Achieves MDSAP Recertification Signifying High Standards in Medical Device Compliance #Liechtenstein #Vaduz #Implantica #RefluxStop #MDSAP

Thiard News@F4F

@newsen.bsky.social

5 months ago

Implantica Aims to Fill Treatment Gap with RefluxStop Amid Competitor Exit Implantica confirms its commitment to enhance RefluxStop availability, addressing the treatment void left by a competitor withdrawing from the European market.

Implantica Aims to Fill Treatment Gap with RefluxStop Amid Competitor Exit #Liechtenstein #Vaduz #Implantica #Medical_Device #RefluxStop

Thiard News@F4F

@newsen.bsky.social

5 months ago

Implantica Receives Positive Feedback from FDA on RefluxStop PMA Submission Implantica AG reports positive feedback from the FDA concerning the PMA submission for their innovative RefluxStop device, aiming to assist millions suffering from acid reflux.

Implantica Receives Positive Feedback from FDA on RefluxStop PMA Submission #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

5 months ago

Excitement Grows for Implantica's RefluxStop® at AFS Meeting Ahead of FDA Approval Implantica's RefluxStop® generated significant excitement at the American Foregut Society meeting, showcasing its innovative approach to treating GERD as it awaits FDA approval.

Excitement Grows for Implantica's RefluxStop® at AFS Meeting Ahead of FDA Approval #Liechtenstein #Vaduz #Implantica #GERD #RefluxStop

Thiard News@F4F

@newsen.bsky.social

6 months ago

Implantica Readies for U.S. Launch by Producing 10,000 RefluxStop® Devices Ahead of FDA Approval Implantica ramps up production of RefluxStop® devices in anticipation of U.S. demand, pending FDA PMA approval, to tackle acid reflux.

Implantica Readies for U.S. Launch by Producing 10,000 RefluxStop® Devices Ahead of FDA Approval #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

7 months ago

Implantica's Q2 2025 Report: Major Advancements for RefluxStop® Implantica's interim report for the first half of 2025 highlights significant strides for RefluxStop®, with positive FDA interactions and expanded market access.

Implantica's Q2 2025 Report: Major Advancements for RefluxStop® #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

7 months ago

Implantica Accelerates Production of RefluxStop® Device in the U.S. Ahead of FDA Approval Implantica announces the completion of a new multi-cavity production tool for its RefluxStop® device, gearing up for U.S. demand pending FDA approval.

Implantica Accelerates Production of RefluxStop® Device in the U.S. Ahead of FDA Approval #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

7 months ago

Implantica Reveals Impressive 5-Year Results for RefluxStop in Clinical Study Implantica AG has released remarkable 5-year results from its clinical study of RefluxStop®, showing significant improvements in the treatment of acid reflux. This groundbreaking device showcases top-notch safety and effectiveness.

Implantica Reveals Impressive 5-Year Results for RefluxStop in Clinical Study #Liechtenstein #Vaduz #Implantica #GERD #RefluxStop

Thiard News@F4F

@newsen.bsky.social

8 months ago

Implantica Releases Groundbreaking 5-Year Clinical Study Results for RefluxStop® Implantica AG unveils the remarkable 5-year clinical data of RefluxStop®, showcasing a new standard in acid reflux treatment. Discover the results!

Implantica Releases Groundbreaking 5-Year Clinical Study Results for RefluxStop® #Liechtenstein #Vaduz #Implantica #GERD #RefluxStop

Thiard News@F4F

@newsen.bsky.social

8 months ago

Implantica Submits Final Module 3 for RefluxStop® FDA PMA Approval in the U.S. Implantica AG has submitted the final module of the FDA PMA application for RefluxStop®. This device aims to revolutionize treatment for acid reflux.

Implantica Submits Final Module 3 for RefluxStop® FDA PMA Approval in the U.S. #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

8 months ago

Implantica Hosts Successful Users Meeting for RefluxStop™ Following NICE Recommendations in the UK The recent meeting gathered top anti-reflux experts in the UK to address the surge in demand for RefluxStop™ after favourable NICE recommendations.

Implantica Hosts Successful Users Meeting for RefluxStop™ Following NICE Recommendations in the UK #London #United_Kingdom #Implantica #GERD #RefluxStop

Thiard News@F4F

@newsen.bsky.social

9 months ago

Implantica's RefluxStop™ Gains Attention at Largest Digestive Disease Conference Implantica's innovative RefluxStop™ procedure generates significant interest among experts at DDW, showcasing its potential impact on anti-reflux surgery.

Implantica's RefluxStop™ Gains Attention at Largest Digestive Disease Conference #United_States #San_Diego #Implantica #RefluxStop #DDW2025

Thiard News@F4F

@newsen.bsky.social

10 months ago

Implantica AG's Annual General Meeting Highlights and Future Strategies The recent AGM of Implantica AG in Liechtenstein highlights key resolutions, financial decisions, and future directions for the medtech company.

Implantica AG's Annual General Meeting Highlights and Future Strategies #Liechtenstein #RefluxStop #Implantica_AG #Ruggell #MedTech_Innovation

Thiard News@F4F

@newsen.bsky.social

10 months ago

Implantica's Q1 2025 Report Highlights Global Growth of RefluxStop™ Device Implantica reveals significant developments in its Q1 2025 report, showcasing the successful feedback from the FDA and global expansion of RefluxStop™.

Implantica's Q1 2025 Report Highlights Global Growth of RefluxStop™ Device #Liechtenstein #Vaduz #Implantica #RefluxStop #Systems

Thiard News@F4F

@newsen.bsky.social

10 months ago

Implantica Expands Accessibility of RefluxStop™ with New Center in Spain Implantica AG has launched a new RefluxStop™ center in Spain's Cantabria region to meet the growing demand for GERD treatment, enhancing surgical options.

Implantica Expands Accessibility of RefluxStop™ with New Center in Spain #Spain #Implantica #RefluxStop #Cantabria

Thiard News@F4F

@newsen.bsky.social

11 months ago

Implantica's 2024 Annual Report: Advancements in Med-Tech Solutions Implantica AG reveals its annual report detailing advancements in medical technology, including RefluxStop™, impacting patient care.

Implantica's 2024 Annual Report: Advancements in Med-Tech Solutions #Liechtenstein #Vaduz #Implantica #RefluxStop #med-tech

Thiard News@F4F

@newsen.bsky.social

1 year ago

Implantica Reports Positive FDA Feedback on RefluxStop Device Submission for Acid Reflux Treatment Implantica AG has received positive feedback from the U.S. FDA regarding its RefluxStop™ PMA Module 2 submission, marking a significant step forward for acid reflux treatment.

Implantica Reports Positive FDA Feedback on RefluxStop Device Submission for Acid Reflux Treatment #FDA #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

1 year ago

Innovative RefluxStop™ Treatment Unveils New Potential for GORD Patients at NHS Educational Gathering Implantica AG has completed its first RefluxStop™ educational meeting at NHS Chelsea Westminster Hospital, focusing on redefining the treatment for GORD, promising significant improvements for patients.

Innovative RefluxStop™ Treatment Unveils New Potential for GORD Patients at NHS Educational Gathering #London #United_Kingdom #Implantica #RefluxStop #GORD

Thiard News@F4F

@newsen.bsky.social

1 year ago

Implantica Joins Nasdaq's First North 25 Index: A Major Milestone for Medtech Implantica AG makes a significant leap by being listed in Nasdaq's First North 25 index, marking its prominence in the medtech sector and FDA focus.

Implantica Joins Nasdaq's First North 25 Index: A Major Milestone for Medtech #NASDAQ #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

1 year ago

Implantica Expands RefluxStop Centers in Spain, Pioneering GERD Treatment Implantica expands its RefluxStop™ treatment network in Spain, now boasting 10 centers dedicated to innovative GERD solutions, enhancing patient care across the region.

Implantica Expands RefluxStop Centers in Spain, Pioneering GERD Treatment #Spain #Implantica #GERD #RefluxStop #Burgos,_Murcia